Biotech & Pharma
Business Development

We have deep experience on both the buy and sell-side, and work with our clients to ensure that partnership, licensing and investment decisions are taken with confidence, along with clear alignment between transaction price and asset value. 

Scroll down to learn more

Pharma Business Development Services


We help companies and investors find new opportunities, working alongside a client’s team to maximize their effectiveness.


We work closely with our clients, using the breadth and depth of our consulting talent to undertake all aspects of due diligence.

Pharma &
Biotech Valuations

Our expert teams develop in-depth valuation models for our clients, helping inform strategic decision-making and investments.

Partnering &

We use a tailored approach to support in- and out-licensing needs, advising clients on both sides of the table.

About our business development capabilities

Alacrita's technical and scientific expertise allows it to deeply understand the science behind biotech and pharmaceutical assets - a core advantage in all business development work that we do. Whether it’s in the ability to recognize potential assets when scouting, in developing the right assumptions for a valuation model, or with delivering due diligence that provides a complete and accurate assessment, knowing the science makes us more effective. 

Our consultants average 20-30 years of industry experience and bring significant first-hand knowledge to every project. Our core team works hand in hand with our Expert Network, which contains over 100 expert business development consultants, and more than 500 high-caliber consultants in total. Having this substantial resource at our fingertips allows us to provide precisely relevant expertise tailored to the specifics of each project, across a full range of product modalities and disease areas.


  • Autoimmune/Immunology
  • Cardiovascular
  • Central Nervous System
  • Congenital Disorders
  • Dermatology/Aesthetics
  • Digestive/GI
  • Ear
  • Endocrine and Metabolic
  • Fibrosis
  • Genitourinary Diseases
  • Haematology
  • Infectious Disease
  • Inflammation/Pain
  • Injuries and Trauma
  • Musculoskeletal
  • Non-medical
  • Oncology
  • Ophthalmology
  • Orphan Diseases
  • Respiratory
  • Urology (non-onc)
  • Women’s Health

Explore our pharma & biotech business development services

Contact Us

Reach out today for more information on our pharma business development services.

Case Studies

Clinical, CMC regulatory & CMC manufacturing due diligence

Challenge: An east coast biotechnology company had reached non-binding terms with an overseas company for development and commercialization rights to a novel anti-cancer product with a...

Due diligence & product development planning of a collaboration

Challenge: A well-capitalized US biotechnology company was considering entry into the CAR-T space through a license and research collaboration with a leading US university with a...

Due diligence of a gene therapy to support in-licensing

Challenge: A mid-sized Japanese pharmaceutical company had made the strategic decision to expand their pipeline and geographical footprint by securing global development and...

Due diligence of a company's commercial forecasts

Challenge: A private equity investor was considering a transaction involving a speciality pharma company dedicated to pediatric medicines. The target company had successfully launched a...

Due diligence of a first-in-class agent for Spinocerebellar Ataxia

Challenge: A Chinese biotech company was evaluating a potential in-license product, a first-in-class agent for the treatment of ataxia and tremors in patients with Spinocerebellar Ataxia...

Technical & commercial due diligence of two development-stage companies

Challenge: An established Alacrita client building a business in the inhaled therapeutics sector asked us to carry out a technical and commercial due diligence of two development stage...